Correlation Between Patient Perception and Findings on Clinical Examination in Chronic Obstructive Pulmonary Disease (COPD) Patients
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Registration Number
- NCT01703416
- Lead Sponsor
- AstraZeneca
- Brief Summary
This is a multi-center, prospective, non-interventional study that aims to evaluate in daily clinical practice the possible correlation between patient perception of the ability to perform morning activities and the physician's assessment during a regular physical exam in patients with Chronic Obstructive Pulmonary Disease (COPD), group C and D.
- Detailed Description
CorRELation between PatIent PErception of the Ability to Perform Morning Activities and Findings on Clinical Examination in COPD Patients receiving inhaled combined therapy (corticosteroid/long acting ß2-agonist) - RELIEF Study
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 500
- Diagnosis of Chronic Obstructive Pulmonary Disease (COPD), group C and D according to GOLD Guidelines, 2011
- Receive inhaled combined therapy for COPD (inhaled corticosteroid / long acting ß2-agonist); this treatment should have been initiated for at least one month before entering the study
- Current or past smokers, of at least 10 pack years
- History of exacerbation of COPD symptoms within the last month before visit 1, inclusive.
- History of asthma or allergic rhinitis.
- History of lung carcinoma or any other respiratory condition that may limit the airflow circulation.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from baseline of patient's general health status upon physical evaluation - visual scale Baseline and 3 months Change from baseline in CDLM (Capacity of Daily Living during the Morning) questionnaire. Baseline and 3 months
- Secondary Outcome Measures
Name Time Method Patient adherence to treatment (by using visual 5 point scale) up to 3 months Number of unscheduled visit (exacerbations, emergency visits) up to 3 months Age (years), gender (male/female), weight (kg), height (cm), place of origin (urban/rural) Day 0 (visit 1) Descriptive statistics will be calculated for this outcome measure
Number of daily walking steps (by using pedometers) up to 3 months